首页 > 最新文献

Journal of hospital medicine最新文献

英文 中文
Gender and work–life balance: Results of a national survey of pediatric hospitalists 性别与工作生活平衡:全国儿科住院医生调查结果。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-27 DOI: 10.1002/jhm.13413
Juliann L. Kim MD, Catherine S. Forster MD, MS, Jessica M. Allan MD, Amanda Schondelmeyer MD, MSc, Holly Ruch-Ross ScD, Lauren Barone MPH, H. Barrett Fromme MD, MHPE

In medicine, difficulty integrating work and home can lead to decreased job satisfaction, diminished well-being, and increased turnover. Understanding the experience of pediatric hospitalists can provide insights into building a stable, long-term workforce. We aim to examine gender differences in work–life balance and parental leave for physicians practicing Pediatric Hospital Medicine.

Methods

This was a cross-sectional survey study of 1096 pediatric hospitalists. Responses were collected via an online survey platform and summarized using descriptive statistics, including frequency distributions and measures of central tendency. A multivariable logistic regression was used to examine associated variables and work–life balance satisfaction. We analyzed free responses on parental leave to provide nuance to quantitative survey data.

Results

Five hundred and sixty-five respondents (52% response rate) completed the survey with 71% women. 343 (62%) prioritize work–life balance in career decision-making. Women report taking on more household responsibilities than their partners (41.4% vs. 8.4%; p < .001) including a larger percentage of caregiving and domestic tasks. Female gender and performing <50% caregiving were associated with decreased work–life balance satisfaction; performing <50% domestic tasks increased satisfaction. Median parental leaves were 4 weeks, with men taking significantly shorter leaves (3.5 vs. 6 weeks; p < .001) and more “paid back” time off.

Conclusion

Work–life balance is an important factor in career decisions for men and women. Women perceive carrying a larger load at home. Qualitative results suggest that parental leave may be inadequate in length and salary support for men and women. This study adds insights into work–life integration in PHM.

在医学界,难以将工作和家庭融为一体会导致工作满意度下降、幸福感降低和人员流动增加。了解儿科医院医生的经历可以为建立一支稳定、长期的工作队伍提供启示。我们旨在研究儿科医院医生在工作与生活平衡和育儿假方面的性别差异:这是一项针对 1096 名儿科医院医生的横断面调查研究。我们通过在线调查平台收集答复,并使用描述性统计方法进行总结,包括频率分布和中心倾向测量。我们使用多变量逻辑回归来研究相关变量和工作与生活平衡满意度。我们对有关育儿假的自由回答进行了分析,以提供定量调查数据的细微差别:共有 565 名受访者(回复率为 52%)完成了调查,其中女性占 71%。343人(62%)在职业决策中优先考虑工作与生活的平衡。与伴侣相比,女性承担了更多的家庭责任(41.4% 对 8.4%;P 结论:工作与生活的平衡是职业决策的重要因素:工作与生活的平衡是男性和女性职业决策的一个重要因素。女性认为在家庭中承担的责任更大。定性结果表明,男性和女性的育儿假在时间长度和薪资支持方面可能存在不足。这项研究为公共健康管理中工作与生活的融合提供了新的视角。
{"title":"Gender and work–life balance: Results of a national survey of pediatric hospitalists","authors":"Juliann L. Kim MD,&nbsp;Catherine S. Forster MD, MS,&nbsp;Jessica M. Allan MD,&nbsp;Amanda Schondelmeyer MD, MSc,&nbsp;Holly Ruch-Ross ScD,&nbsp;Lauren Barone MPH,&nbsp;H. Barrett Fromme MD, MHPE","doi":"10.1002/jhm.13413","DOIUrl":"10.1002/jhm.13413","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 <p>In medicine, difficulty integrating work and home can lead to decreased job satisfaction, diminished well-being, and increased turnover. Understanding the experience of pediatric hospitalists can provide insights into building a stable, long-term workforce. We aim to examine gender differences in work–life balance and parental leave for physicians practicing Pediatric Hospital Medicine.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a cross-sectional survey study of 1096 pediatric hospitalists. Responses were collected via an online survey platform and summarized using descriptive statistics, including frequency distributions and measures of central tendency. A multivariable logistic regression was used to examine associated variables and work–life balance satisfaction. We analyzed free responses on parental leave to provide nuance to quantitative survey data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Five hundred and sixty-five respondents (52% response rate) completed the survey with 71% women. 343 (62%) prioritize work–life balance in career decision-making. Women report taking on more household responsibilities than their partners (41.4% vs. 8.4%; <i>p</i> &lt; .001) including a larger percentage of caregiving and domestic tasks. Female gender and performing &lt;50% caregiving were associated with decreased work–life balance satisfaction; performing &lt;50% domestic tasks increased satisfaction. Median parental leaves were 4 weeks, with men taking significantly shorter leaves (3.5 vs. 6 weeks; <i>p</i> &lt; .001) and more “paid back” time off.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Work–life balance is an important factor in career decisions for men and women. Women perceive carrying a larger load at home. Qualitative results suggest that parental leave may be inadequate in length and salary support for men and women. This study adds insights into work–life integration in PHM.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 10","pages":"894-904"},"PeriodicalIF":2.4,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and risk factors for central venous access device failure in hospitalized adults: A multivariable analysis of 1892 catheters 住院成人中心静脉通路装置故障的发生率和风险因素:对 1892 个导管的多变量分析。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-27 DOI: 10.1002/jhm.13414
Amanda Corley RN, MAdvPrac, PhD, Ruth H. Royle RN, MEcon, Nicole Marsh RN, MAdvPrac, PhD, Emily N. Larsen RN, GDipHlthRes, PhD (Cand), E. Geoffrey Playford MBBS (Hons), MMed (Clin Epi), PhD, FRACP, FRCPA, Matthew R. McGrail PhD, Naomi Runnegar MBBS, FRACP, FRCPA, Robert S. Ware BSc, PhD, Nicole C. Gavin RN, MAdvPrac, PhD, Evan Alexandrou RN, PhD, Marghie Murgo RN, MCritCareNurs, John R. Gowardman MBChB, FCICM, FRACP, Adrian Regli MD, PhD, FCICM, Claire M. Rickard RN, PhD

Background

Central venous access devices (CVADs) allow intravenous therapy, haemodynamic monitoring and blood sampling but many fail before therapy completion.

Objective

To quantify CVAD failure and complications; and identify risk factors.

Designs, Settings, and Participants

Secondary analysis of multicentre randomised controlled trial including patients aged ≥16 years with a non-tunnelled CVAD (NTCVAD), peripherally-inserted central catheter (PICC) or tunnelled CVAD (TCVAD). Primary outcome was incidence of all-cause CVAD failure (central line-associated bloodstream infection [CLABSI], occlusion, accidental dislodgement, catheter fracture, thrombosis, pain). Secondary outcomes were CLABSI, occlusion and dislodgement. Cox regression was used to report time-to-event associations.

Results

In 1892 CVADs, all-cause failure occurred in 10.2% of devices: 49 NTCVADs (6.1%); 100 PICCs (13.2%); 44 TCVADs (13.4%). Failure rates for CLABSI, occlusion and dislodgement were 5.3%, 1.8%, and 1.7%, respectively. Independent CLABSI predictors were blood product administration through PICCs (hazard ratio (HR) 2.62, 95% confidence interval (CI) 1.24–5.55); and in TCVADs, one or two lumens, compared with three to four (HR 3.36, 95%CI 1.68–6.71), intravenous chemotherapy (HR 2.96, 95%CI 1.31–6.68), and diabetes (HR 3.25, 95%CI 1.40–7.57). Independent factors protective for CLABSI include antimicrobial NTCVADs (HR 0.23, 95%CI 0.08–0.63) and lipids in TCVADs (HR 0.32, 95%CI 0.14–0.72). NTCVADs inserted at another hospital (HR 7.06, 95%CI 1.48–33.7) and baseline infection in patients with PICCs (HR 2.72, 95%CI 1.08–6.83) were predictors for dislodgement. No independent occlusion predictors were found. Modifiable risk factors were identified for CVAD failure, which occurred for 1-in-10 catheters. Strict infection prevention measures and improved CVAD securement could reduce CLABSI and dislodgement risk.

背景中心静脉通路装置(CVAD)可用于静脉治疗、血流动力学监测和血液采样,但许多装置在治疗完成前就已失效:量化 CVAD 的故障和并发症,并确定风险因素:多中心随机对照试验的二次分析,包括年龄≥16 岁、使用非隧道式 CVAD(NTCVAD)、外周置入中心导管(PICC)或隧道式 CVAD(TCVAD)的患者。主要结果是全因 CVAD 故障(中心静脉相关血流感染 [CLABSI]、闭塞、意外脱落、导管断裂、血栓形成、疼痛)的发生率。次要结果为 CLABSI、闭塞和脱落。Cox回归用于报告时间到事件之间的关联:结果:在 1892 台 CVAD 中,10.2% 的设备发生了全因故障:49台NTCVAD(6.1%);100台PICC(13.2%);44台TCVAD(13.4%)。CLABSI、闭塞和脱落的失败率分别为 5.3%、1.8% 和 1.7%。预测 CLABSI 的独立因素包括:通过 PICC 给血制品(危险比 (HR) 2.62,95% 置信区间 (CI):1.24-5.55);TCVAD 只有一个或两个管腔,而 TCVAD 有三到四个管腔(HR:3.36,95% 置信区间 (CI):1.68-6.71);静脉化疗(HR:2.96,95% 置信区间 (CI):1.31-6.68);糖尿病(HR:3.25,95% 置信区间 (CI):1.40-7.57)。CLABSI的独立保护因素包括抗菌NTCVAD(HR 0.23,95%CI 0.08-0.63)和TCVAD中的脂质(HR 0.32,95%CI 0.14-0.72)。在其他医院插入的 NTCVAD(HR 7.06,95%CI 1.48-33.7)和 PICC 患者的基线感染(HR 2.72,95%CI 1.08-6.83)是脱落的预测因素。没有发现独立的闭塞预测因素。CVAD 失效的可改变风险因素已经确定,每 10 个导管中就有 1 个发生失效。严格的感染预防措施和改进的 CVAD 固定可降低 CLABSI 和脱落风险。
{"title":"Incidence and risk factors for central venous access device failure in hospitalized adults: A multivariable analysis of 1892 catheters","authors":"Amanda Corley RN, MAdvPrac, PhD,&nbsp;Ruth H. Royle RN, MEcon,&nbsp;Nicole Marsh RN, MAdvPrac, PhD,&nbsp;Emily N. Larsen RN, GDipHlthRes, PhD (Cand),&nbsp;E. Geoffrey Playford MBBS (Hons), MMed (Clin Epi), PhD, FRACP, FRCPA,&nbsp;Matthew R. McGrail PhD,&nbsp;Naomi Runnegar MBBS, FRACP, FRCPA,&nbsp;Robert S. Ware BSc, PhD,&nbsp;Nicole C. Gavin RN, MAdvPrac, PhD,&nbsp;Evan Alexandrou RN, PhD,&nbsp;Marghie Murgo RN, MCritCareNurs,&nbsp;John R. Gowardman MBChB, FCICM, FRACP,&nbsp;Adrian Regli MD, PhD, FCICM,&nbsp;Claire M. Rickard RN, PhD","doi":"10.1002/jhm.13414","DOIUrl":"10.1002/jhm.13414","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Central venous access devices (CVADs) allow intravenous therapy, haemodynamic monitoring and blood sampling but many fail before therapy completion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To quantify CVAD failure and complications; and identify risk factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Designs, Settings, and Participants</h3>\u0000 \u0000 <p>Secondary analysis of multicentre randomised controlled trial including patients aged ≥16 years with a non-tunnelled CVAD (NTCVAD), peripherally-inserted central catheter (PICC) or tunnelled CVAD (TCVAD). Primary outcome was incidence of all-cause CVAD failure (central line-associated bloodstream infection [CLABSI], occlusion, accidental dislodgement, catheter fracture, thrombosis, pain). Secondary outcomes were CLABSI, occlusion and dislodgement. Cox regression was used to report time-to-event associations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In 1892 CVADs, all-cause failure occurred in 10.2% of devices: 49 NTCVADs (6.1%); 100 PICCs (13.2%); 44 TCVADs (13.4%). Failure rates for CLABSI, occlusion and dislodgement were 5.3%, 1.8%, and 1.7%, respectively. Independent CLABSI predictors were blood product administration through PICCs (hazard ratio (HR) 2.62, 95% confidence interval (CI) 1.24–5.55); and in TCVADs, one or two lumens, compared with three to four (HR 3.36, 95%CI 1.68–6.71), intravenous chemotherapy (HR 2.96, 95%CI 1.31–6.68), and diabetes (HR 3.25, 95%CI 1.40–7.57). Independent factors protective for CLABSI include antimicrobial NTCVADs (HR 0.23, 95%CI 0.08–0.63) and lipids in TCVADs (HR 0.32, 95%CI 0.14–0.72). NTCVADs inserted at another hospital (HR 7.06, 95%CI 1.48–33.7) and baseline infection in patients with PICCs (HR 2.72, 95%CI 1.08–6.83) were predictors for dislodgement. No independent occlusion predictors were found. Modifiable risk factors were identified for CVAD failure, which occurred for 1-in-10 catheters. Strict infection prevention measures and improved CVAD securement could reduce CLABSI and dislodgement risk.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 10","pages":"905-917"},"PeriodicalIF":2.4,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jhm.13414","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic clinical decision support for pneumonia in the emergency department: A randomized trial 急诊科肺炎预后临床决策支持:随机试验。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-26 DOI: 10.1002/jhm.13391
Derek J. Williams MD, MPH, Hui Nian PhD, Srinivasan Suresh MD, MBA, Jason Slagle PhD, Stephen Gradwohl MD, MSACI, Jakobi Johnson BS, Justine Stassun MS, Carrie Reale RN, MSN, Shari L. Just RN, MSN, Nancy S. Rixe MD, Russ Beebe BA, Donald H. Arnold MD, MPH, Robert W. Turer MD, James W. Antoon MD, PhD, Laura F. Sartori MD, MPH, Robert E. Freundlich MD, MSCI, Carlos G. Grijalva MD, MPH, Joshua C. Smith PhD, Asli O. Weitkamp PhD, MSACI, Matthew B. Weinger MD, MS, Yuwei Zhu MD, MS, Judith M. Martin MD

Background

Hospitalization rates for childhood pneumonia vary widely. Risk-based clinical decision support (CDS) interventions may reduce unwarranted variation.

Methods

We conducted a pragmatic randomized trial in two US pediatric emergency departments (EDs) comparing electronic health record (EHR)-integrated prognostic CDS versus usual care for promoting appropriate ED disposition in children (<18 years) with pneumonia. Encounters were randomized 1:1 to usual care versus custom CDS featuring a validated pneumonia severity score predicting risk for severe in-hospital outcomes. Clinicians retained full decision-making authority. The primary outcome was inappropriate ED disposition, defined as early transition to lower- or higher-level care. Safety and implementation outcomes were also evaluated.

Results

The study enrolled 536 encounters (269 usual care and 267 CDS). Baseline characteristics were similar across arms. Inappropriate disposition occurred in 3% of usual care encounters and 2% of CDS encounters (adjusted odds ratio: 0.99, 95% confidence interval: [0.32, 2.95]). Length of stay was also similar and adverse safety outcomes were uncommon in both arms. The tool's custom user interface and content were viewed as strengths by surveyed clinicians (>70% satisfied). Implementation barriers include intrinsic (e.g., reaching the right person at the right time) and extrinsic factors (i.e., global pandemic).

Conclusions

EHR-based prognostic CDS did not improve ED disposition decisions for children with pneumonia. Although the intervention's content was favorably received, low subject accrual and workflow integration problems likely limited effectiveness. Clinical Trials Registration: NCT06033079.

背景:儿童肺炎的住院率差异很大。基于风险的临床决策支持(CDS)干预措施可减少不必要的差异:方法:我们在美国两家儿科急诊室(ED)进行了一项实用随机试验,比较了电子健康记录(EHR)集成预后 CDS 与常规护理在促进适当的儿童急诊室处置方面的效果(结果:研究共招募了 536 人次(269 人次为常规护理,267 人次为 CDS)。各组的基线特征相似。不恰当处置发生在 3% 的常规护理和 2% 的 CDS 中(调整后的几率比:0.99,95% 置信区间:[0.32, 2.95]),住院时间也相似,不良安全结果在两组中都不常见。接受调查的临床医生认为该工具的定制用户界面和内容是其优势所在(满意度超过 70%)。实施障碍包括内在因素(如在正确的时间联系到正确的人)和外在因素(如全球大流行):结论:基于电子病历的预后性 CDS 并未改善急诊室对肺炎患儿的处置决定。虽然干预措施的内容受到好评,但受试者较少以及工作流程整合问题可能限制了其有效性。临床试验注册:NCT06033079。
{"title":"Prognostic clinical decision support for pneumonia in the emergency department: A randomized trial","authors":"Derek J. Williams MD, MPH,&nbsp;Hui Nian PhD,&nbsp;Srinivasan Suresh MD, MBA,&nbsp;Jason Slagle PhD,&nbsp;Stephen Gradwohl MD, MSACI,&nbsp;Jakobi Johnson BS,&nbsp;Justine Stassun MS,&nbsp;Carrie Reale RN, MSN,&nbsp;Shari L. Just RN, MSN,&nbsp;Nancy S. Rixe MD,&nbsp;Russ Beebe BA,&nbsp;Donald H. Arnold MD, MPH,&nbsp;Robert W. Turer MD,&nbsp;James W. Antoon MD, PhD,&nbsp;Laura F. Sartori MD, MPH,&nbsp;Robert E. Freundlich MD, MSCI,&nbsp;Carlos G. Grijalva MD, MPH,&nbsp;Joshua C. Smith PhD,&nbsp;Asli O. Weitkamp PhD, MSACI,&nbsp;Matthew B. Weinger MD, MS,&nbsp;Yuwei Zhu MD, MS,&nbsp;Judith M. Martin MD","doi":"10.1002/jhm.13391","DOIUrl":"10.1002/jhm.13391","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hospitalization rates for childhood pneumonia vary widely. Risk-based clinical decision support (CDS) interventions may reduce unwarranted variation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a pragmatic randomized trial in two US pediatric emergency departments (EDs) comparing electronic health record (EHR)-integrated prognostic CDS versus usual care for promoting appropriate ED disposition in children (&lt;18 years) with pneumonia. Encounters were randomized 1:1 to usual care versus custom CDS featuring a validated pneumonia severity score predicting risk for severe in-hospital outcomes. Clinicians retained full decision-making authority. The primary outcome was inappropriate ED disposition, defined as early transition to lower- or higher-level care. Safety and implementation outcomes were also evaluated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study enrolled 536 encounters (269 usual care and 267 CDS). Baseline characteristics were similar across arms. Inappropriate disposition occurred in 3% of usual care encounters and 2% of CDS encounters (adjusted odds ratio: 0.99, 95% confidence interval: [0.32, 2.95]). Length of stay was also similar and adverse safety outcomes were uncommon in both arms. The tool's custom user interface and content were viewed as strengths by surveyed clinicians (&gt;70% satisfied). Implementation barriers include intrinsic (e.g., reaching the right person at the right time) and extrinsic factors (i.e., global pandemic).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>EHR-based prognostic CDS did not improve ED disposition decisions for children with pneumonia. Although the intervention's content was favorably received, low subject accrual and workflow integration problems likely limited effectiveness. Clinical Trials Registration: NCT06033079.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 9","pages":"802-811"},"PeriodicalIF":2.4,"publicationDate":"2024-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors associated with escalation of care in a quaternary academic hospital at home program 与四级学术医院居家计划中护理升级相关的风险因素。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-26 DOI: 10.1002/jhm.13411
Jed Colt Cowdell MD, MBA, Ellen Lopez APRN, Amy Haney DMSc, PA-C, Luke Myers, Barbara Coble RN, Michael G. Heckman MS, Ryan T. Moerer BSc, Margaret R. Paulson DO, Michael Maniaci MD

Background

Hospital-at-home has become a more recognized way to care for patients requiring inpatient hospitalization. At times, these patients may require escalation of care (transfer from home back to the brick-and-mortar (BAM) hospital for ongoing hospitalization care needs), a process that has not been extensively studied.

Objective

To evaluate what patient factors contribute to escalations of care in the hospital-at-home delivery model.

Designs, Settings, and Participants

We conducted a retrospective review of all patients admitted to Mayo Clinic's Advanced Care at Home (ACH) program from January 1, 2022 to December 31, 2022.

Intervention

None.

Main Outcomes and Measures

Patient information was collected via electronic health record including demographic, socioeconomic, and clinical status. The primary outcome was the of occurrence of an escalation.

Results

A total of 904 patients were included, of whom 80 (8.8%) required an escalation of care. In multivariable analysis, risk of an escalation was significantly higher for patients who were married or had a life partner (HR: 1.82, 95% CI: 1.05–3.23, p = .033) for patients admitted with procedure-related disorders (HR: 2.61, 95% CI: 1.35–5.05, p = .005) and patients with an increased mortality risk score (HR [per each 1–category increase] = 1.86, 95% CI: 1.39–2.50, p < .001).

背景:对于需要住院治疗的病人来说,在家住院治疗已成为一种公认的护理方式。有时,这些患者可能需要护理升级(从家中转回实体(BAM)医院以满足持续的住院护理需求),而这一过程尚未得到广泛研究:目的:评估在医院到家服务模式中,哪些患者因素会导致护理升级:我们对2022年1月1日至2022年12月31日期间梅奥诊所高级居家护理(ACH)项目收治的所有患者进行了回顾性分析:无:通过电子健康记录收集患者信息,包括人口、社会经济和临床状况。主要结果是发生升级:结果:共纳入 904 名患者,其中 80 人(8.8%)需要升级护理。在多变量分析中,已婚或有生活伴侣的患者(HR:1.82,95% CI:1.05-3.23,p = .033)、因手术相关疾病入院的患者(HR:2.61,95% CI:1.35-5.05,p = .005)和死亡率风险评分增加的患者(HR [每增加 1 个类别] = 1.86,95% CI:1.39-2.50,p = .005)发生护理升级的风险明显更高。
{"title":"Risk factors associated with escalation of care in a quaternary academic hospital at home program","authors":"Jed Colt Cowdell MD, MBA,&nbsp;Ellen Lopez APRN,&nbsp;Amy Haney DMSc, PA-C,&nbsp;Luke Myers,&nbsp;Barbara Coble RN,&nbsp;Michael G. Heckman MS,&nbsp;Ryan T. Moerer BSc,&nbsp;Margaret R. Paulson DO,&nbsp;Michael Maniaci MD","doi":"10.1002/jhm.13411","DOIUrl":"10.1002/jhm.13411","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hospital-at-home has become a more recognized way to care for patients requiring inpatient hospitalization. At times, these patients may require escalation of care (transfer from home back to the brick-and-mortar (BAM) hospital for ongoing hospitalization care needs), a process that has not been extensively studied.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate what patient factors contribute to escalations of care in the hospital-at-home delivery model.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Designs, Settings, and Participants</h3>\u0000 \u0000 <p>We conducted a retrospective review of all patients admitted to Mayo Clinic's Advanced Care at Home (ACH) program from January 1, 2022 to December 31, 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Intervention</h3>\u0000 \u0000 <p>None.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcomes and Measures</h3>\u0000 \u0000 <p>Patient information was collected via electronic health record including demographic, socioeconomic, and clinical status. The primary outcome was the of occurrence of an escalation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 904 patients were included, of whom 80 (8.8%) required an escalation of care. In multivariable analysis, risk of an escalation was significantly higher for patients who were married or had a life partner (HR: 1.82, 95% CI: 1.05–3.23, <i>p</i> = .033) for patients admitted with procedure-related disorders (HR: 2.61, 95% CI: 1.35–5.05, <i>p</i> = .005) and patients with an increased mortality risk score (HR [per each 1–category increase] = 1.86, 95% CI: 1.39–2.50, <i>p</i> &lt; .001).</p>\u0000 </section>\u0000 </div>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 10","pages":"886-893"},"PeriodicalIF":2.4,"publicationDate":"2024-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical guideline highlights for the hospitalist: GOLD COPD update 2024 住院医生临床指南要点:GOLD COPD 2024 年更新版。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-26 DOI: 10.1002/jhm.13416
Teresa Cornelius MD, MPH

GUIDELINE TITLE: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2024 Report)

RELEASE DATE: December 4, 2023

PRIOR VERSIONS: Initial report was released in 2001 with major revisions in 2006, 2011, 2017, and 2023. This 2024 release is an update to the 2023 major revision

DEVELOPER: Global Initiative for Chronic Obstructive Lung Disease (GOLD)

FUNDING SOURCE: GOLD

TARGET POPULATION: Adults with a diagnosis of or at risk for COPD

指南标题:慢性阻塞性肺疾病诊断、管理和预防全球战略(2024 年报告) 发布日期:2023 年 12 月 4 日 以前版本:最初的报告于 2001 年发布,并于 2006 年、2011 年、2017 年和 2023 年进行了主要修订。2024 年发布的报告是对 2023 年主要修订版的更新:慢性阻塞性肺病全球倡议(GOLD) 资金来源:GOLD目标人群:诊断为慢性阻塞性肺病或有此风险的成年人。
{"title":"Clinical guideline highlights for the hospitalist: GOLD COPD update 2024","authors":"Teresa Cornelius MD, MPH","doi":"10.1002/jhm.13416","DOIUrl":"10.1002/jhm.13416","url":null,"abstract":"<p><b>GUIDELINE TITLE</b>: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2024 Report)</p><p><b>RELEASE DATE</b>: December 4, 2023</p><p><b>PRIOR VERSIONS</b>: Initial report was released in 2001 with major revisions in 2006, 2011, 2017, and 2023. This 2024 release is an update to the 2023 major revision</p><p><b>DEVELOPER</b>: Global Initiative for Chronic Obstructive Lung Disease (GOLD)</p><p><b>FUNDING SOURCE</b>: GOLD</p><p><b>TARGET POPULATION</b>: Adults with a diagnosis of or at risk for COPD</p>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 9","pages":"818-820"},"PeriodicalIF":2.4,"publicationDate":"2024-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jhm.13416","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No lack of movement 不缺乏运动。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-23 DOI: 10.1002/jhm.13412
Danielle Minji Jung MD, Maya Narayanan MD, MPH, Neha Deshpande MD, Elise P. Lu MD, PhD, Ami Cuneo MD
{"title":"No lack of movement","authors":"Danielle Minji Jung MD,&nbsp;Maya Narayanan MD, MPH,&nbsp;Neha Deshpande MD,&nbsp;Elise P. Lu MD, PhD,&nbsp;Ami Cuneo MD","doi":"10.1002/jhm.13412","DOIUrl":"10.1002/jhm.13412","url":null,"abstract":"","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 10","pages":"948-952"},"PeriodicalIF":2.4,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous thromboembolism performance measurement in the United States: An evolving landscape with many stakeholders 美国的静脉血栓栓塞症绩效衡量:利益相关者众多,格局不断变化。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-21 DOI: 10.1002/jhm.13385
Barbara I. Braun PhD, Karen M. Kolbusz MBA, BSN, RN, Michele R. Bozikis MPH, Stephen P. Schmaltz PhD, Karon Abe PhD, CAPT, USPHS, Nimia L. Reyes MD, MPH, Michelle N. Dardis MSN, MBA, RN

Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a life-threatening, costly, and common preventable complication associated with hospitalization. Although VTE prevention strategies such as risk assessment and prophylaxis are available, they are not applied uniformly or systematically across US hospitals and healthcare systems. Hospital-level performance measurement has been used nationally to promote standardized approaches for VTE prevention and incentivize the adoption of guideline-based care management. Though most measures reflect care processes rather than outcomes, certain domains including diagnosis, treatment, and continuity of care remain unmeasured. In this article, we describe the development of VTE prevention measures from various stakeholders, measure strengths and limitations, publicly reported rates, the impact of technology and health policy on measure use, and perspectives on future options for surveillance and performance monitoring.

静脉血栓栓塞症(VTE),包括深静脉血栓形成和肺栓塞,是一种威胁生命、代价高昂且常见的可预防的住院并发症。虽然有风险评估和预防等 VTE 预防策略,但这些策略并没有在美国的医院和医疗保健系统中得到统一或系统的应用。医院层面的绩效考核已在全国范围内推广标准化的 VTE 预防方法,并鼓励采用基于指南的护理管理。尽管大多数衡量标准反映的是护理流程而非结果,但包括诊断、治疗和护理连续性在内的某些领域仍未得到衡量。在本文中,我们将介绍各利益相关方制定 VTE 预防措施的情况、措施的优势和局限性、公开报道的比率、技术和卫生政策对措施使用的影响,以及对未来监测和绩效监控方案的看法。
{"title":"Venous thromboembolism performance measurement in the United States: An evolving landscape with many stakeholders","authors":"Barbara I. Braun PhD,&nbsp;Karen M. Kolbusz MBA, BSN, RN,&nbsp;Michele R. Bozikis MPH,&nbsp;Stephen P. Schmaltz PhD,&nbsp;Karon Abe PhD, CAPT, USPHS,&nbsp;Nimia L. Reyes MD, MPH,&nbsp;Michelle N. Dardis MSN, MBA, RN","doi":"10.1002/jhm.13385","DOIUrl":"10.1002/jhm.13385","url":null,"abstract":"<p>Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a life-threatening, costly, and common preventable complication associated with hospitalization. Although VTE prevention strategies such as risk assessment and prophylaxis are available, they are not applied uniformly or systematically across US hospitals and healthcare systems. Hospital-level performance measurement has been used nationally to promote standardized approaches for VTE prevention and incentivize the adoption of guideline-based care management. Though most measures reflect care processes rather than outcomes, certain domains including diagnosis, treatment, and continuity of care remain unmeasured. In this article, we describe the development of VTE prevention measures from various stakeholders, measure strengths and limitations, publicly reported rates, the impact of technology and health policy on measure use, and perspectives on future options for surveillance and performance monitoring.</p>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 9","pages":"827-840"},"PeriodicalIF":2.4,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141072480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of health confidence with hospital length of stay and readmission 健康信心与住院时间和再入院率的关系。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-16 DOI: 10.1002/jhm.13405
Ashley E. Brown MD, MS, Valerie G. Press MD, MPH, David O. Meltzer MD, PhD

Background

Length of stay (LOS) is an important measure of hospital quality and may be impacted by patient participation. However, concepts of patient participation, like health confidence, have received little examination in hospitalized patients' LOS, especially in diverse populations.

Objective

To determine if the Health Confidence Score (HCS) is associated with hospital LOS and readmission in a socioeconomically diverse population.

Designs, Settings, and Participants

We conducted a prospective cohort study in 2022 of adult general medicine patients at an academic hospital in Chicago, Illinois.

Intervention

None.

Main Outcome and Measures

Patient-reported responses to the HCS (scored 0 [lowest health confidence] to ‒12 [highest health confidence]), as well as demographic, socioeconomic, and clinical questions, were collected. Primary outcome was LOS and secondary outcomes were 30- and 90-day readmission.

Results

Among 2797 socioeconomically diverse patients who completed the survey (response rate 28.5%), there was an average HCS of 9.19 (SD 2.68, range 0–12). Using linear regression, patients with high HCS (HCS ≥ 9) had a 1.53-day lower LOS (p < .01, 95% confidence interval [CI] [–2.11, –0.95]) than patients with a low HCS (HCS < 9). This association remained when examining individual HCS questions and controlling for covariates. In logistic regression, HCS was not significantly associated with readmission, but the question “I am involved in decisions about me” (adjusted model: odds ratio 0.83; 95% CI [0.71, 0.96]; p = .01) was associated with 90-day readmission.

背景:住院时间(LOS)是衡量医院质量的一个重要指标,可能会受到患者参与的影响。然而,病人参与的概念,如健康信心,在住院病人的 LOS 中很少得到研究,尤其是在不同的人群中:目的:确定健康信心分数(HCS)是否与社会经济多元化人群的住院时间和再入院率相关:我们于 2022 年在伊利诺伊州芝加哥市的一家学术医院对成人全科患者进行了一项前瞻性队列研究:主要结果和测量指标主要结果和测量方法:收集患者对 HCS(从 0 分[最低健康信心]到 -12 分[最高健康信心])的反应,以及人口、社会经济和临床问题。主要结果为住院日,次要结果为 30 天和 90 天再入院:在完成调查的 2797 名社会经济背景各异的患者中(回复率为 28.5%),平均健康信心指数为 9.19(标准差为 2.68,范围为 0-12)。通过线性回归,高 HCS(HCS ≥ 9)患者的 LOS 比低 HCS(HCS < 9)患者低 1.53 天(p < .01,95% CI [-2.11, -0.95])。当检查单个 HCS 问题并控制协变量时,这种关联仍然存在。在逻辑回归中,HCS 与再入院无显著相关性,但 "我参与了有关我的决策"(调整模型:OR 0.83;95% CI [0.71,0.96];p = .01)与 90 天再入院相关。
{"title":"Association of health confidence with hospital length of stay and readmission","authors":"Ashley E. Brown MD, MS,&nbsp;Valerie G. Press MD, MPH,&nbsp;David O. Meltzer MD, PhD","doi":"10.1002/jhm.13405","DOIUrl":"10.1002/jhm.13405","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Length of stay (LOS) is an important measure of hospital quality and may be impacted by patient participation. However, concepts of patient participation, like health confidence, have received little examination in hospitalized patients' LOS, especially in diverse populations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To determine if the Health Confidence Score (HCS) is associated with hospital LOS and readmission in a socioeconomically diverse population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Designs, Settings, and Participants</h3>\u0000 \u0000 <p>We conducted a prospective cohort study in 2022 of adult general medicine patients at an academic hospital in Chicago, Illinois.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Intervention</h3>\u0000 \u0000 <p>None.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome and Measures</h3>\u0000 \u0000 <p>Patient-reported responses to the HCS (scored 0 [<i>lowest health confidence</i>] to ‒12 [<i>highest health confidence</i>]), as well as demographic, socioeconomic, and clinical questions, were collected. Primary outcome was LOS and secondary outcomes were 30- and 90-day readmission.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 2797 socioeconomically diverse patients who completed the survey (response rate 28.5%), there was an average HCS of 9.19 (SD 2.68, range 0–12). Using linear regression, patients with high HCS (HCS ≥ 9) had a 1.53-day lower LOS (<i>p</i> &lt; .01, 95% confidence interval [CI] [–2.11, –0.95]) than patients with a low HCS (HCS &lt; 9). This association remained when examining individual HCS questions and controlling for covariates. In logistic regression, HCS was not significantly associated with readmission, but the question “I am involved in decisions about me” (adjusted model: odds ratio 0.83; 95% CI [0.71, 0.96]; <i>p</i> = .01) was associated with 90-day readmission.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 9","pages":"794-801"},"PeriodicalIF":2.4,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jhm.13405","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140945968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The sepsis coding intensity measure: Is this the scalpel that will dissect out illness severity or is it still too blunt for the task? 脓毒症编码强度测量:这是一把能剖析疾病严重程度的手术刀,还是仍然太钝?
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-15 DOI: 10.1002/jhm.13410
Harris L. Carmichael MD, MSHP, Ajay Bhasin MD, MS, Gregory W. Ruhnke MD, MS, MPH
{"title":"The sepsis coding intensity measure: Is this the scalpel that will dissect out illness severity or is it still too blunt for the task?","authors":"Harris L. Carmichael MD, MSHP,&nbsp;Ajay Bhasin MD, MS,&nbsp;Gregory W. Ruhnke MD, MS, MPH","doi":"10.1002/jhm.13410","DOIUrl":"10.1002/jhm.13410","url":null,"abstract":"","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 9","pages":"866-867"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140946068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking barriers, building faculty: A qualitative analysis to exploring faculty development in academic hospital medicine 打破障碍,建设师资队伍:定性分析探索医院医学学术领域的师资发展。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-15 DOI: 10.1002/jhm.13406
Jack Badawy MD, Matthew Sakumoto MD, Elizabeth Murphy MD, David Schmit MD, Christine Davis MS, Ankur Segon MD, MPH, Andrew Auerbach MD, Marisha Burden MD, MBA

Background

Hospital medicine (HM) continues to be primarily composed of junior hospitalists and research has highlighted a paucity of mentors and academic output. Faculty advancement programs have been identified as a means to support junior hospitalists in their career trajectories and to advance the field. The optimal approach to supporting faculty development (FD) efforts is not known.

Objective

To understand hospitalist groups' approaches to FD, including efforts that were perceived to be effective, and to identify barriers as well as potential future directions for FD.

Design

Rapid qualitative methods were utilized including templated summaries and matrix analysis to identify major themes.

Setting and Participants

Virtual focus groups with hospitalists in the Hospital Medicine Reengineering Network (HOMERuN).

Main Outcome and Measures

Qualitative themes.

Results

Nineteen individuals from 17 unique institutions from across the United States in May 2022 participated in seven focus groups. Four key themes emerged from the study and included (1) academic hospitalist programs face multifaceted challenges and barriers to FD in HM, (2) groups have embraced a diversity of structures and frameworks, (3) due to clinical volumes, FD programs have had to adapt and evolve to meet FD needs, and (4) participants identified multiple areas for improvement, including defining tangible outcomes of FD programs and creating a repository of FD material which can be shared widely.

背景:医院医学(HM)仍然主要由初级住院医师组成,研究表明导师和学术成果匮乏。教员晋升计划被认为是支持初级医院医生职业发展和推动该领域进步的一种手段。目前尚不清楚支持师资发展(FD)工作的最佳方法:目的:了解住院医师团体的师资发展方法,包括他们认为有效的工作,并确定师资发展的障碍和潜在的未来方向:设计:采用快速定性方法,包括模板摘要和矩阵分析,以确定主要主题:主要结果和测量指标:定性主题 结果:2022 年 5 月,来自全美 17 家不同机构的 19 人参加了 7 个焦点小组。研究中出现了四个关键主题,包括:(1)医院医学学术项目面临着多方面的挑战和障碍,(2)各小组采用了多种结构和框架,(3)由于临床量的增加,医院医学项目不得不进行调整和演变,以满足医院医学的需求,(4)参与者确定了多个需要改进的领域,包括确定医院医学项目的实际成果,以及创建一个可广泛共享的医院医学材料库。
{"title":"Breaking barriers, building faculty: A qualitative analysis to exploring faculty development in academic hospital medicine","authors":"Jack Badawy MD,&nbsp;Matthew Sakumoto MD,&nbsp;Elizabeth Murphy MD,&nbsp;David Schmit MD,&nbsp;Christine Davis MS,&nbsp;Ankur Segon MD, MPH,&nbsp;Andrew Auerbach MD,&nbsp;Marisha Burden MD, MBA","doi":"10.1002/jhm.13406","DOIUrl":"10.1002/jhm.13406","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hospital medicine (HM) continues to be primarily composed of junior hospitalists and research has highlighted a paucity of mentors and academic output. Faculty advancement programs have been identified as a means to support junior hospitalists in their career trajectories and to advance the field. The optimal approach to supporting faculty development (FD) efforts is not known.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To understand hospitalist groups' approaches to FD, including efforts that were perceived to be effective, and to identify barriers as well as potential future directions for FD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Rapid qualitative methods were utilized including templated summaries and matrix analysis to identify major themes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting and Participants</h3>\u0000 \u0000 <p>Virtual focus groups with hospitalists in the Hospital Medicine Reengineering Network (HOMERuN).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome and Measures</h3>\u0000 \u0000 <p>Qualitative themes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Nineteen individuals from 17 unique institutions from across the United States in May 2022 participated in seven focus groups. Four key themes emerged from the study and included (1) academic hospitalist programs face multifaceted challenges and barriers to FD in HM, (2) groups have embraced a diversity of structures and frameworks, (3) due to clinical volumes, FD programs have had to adapt and evolve to meet FD needs, and (4) participants identified multiple areas for improvement, including defining tangible outcomes of FD programs and creating a repository of FD material which can be shared widely.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15883,"journal":{"name":"Journal of hospital medicine","volume":"19 9","pages":"787-793"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140945969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of hospital medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1